Article and Video CATEGORIES

Cancer Journey

Search By

 Dr. Zofia Piotrowska is with the Thoracic Oncology Program at Massachusetts General Hospital Cancer Center in Boston, Massachusetts.  More information on Dr. Piotrowska is available here: https://www.massgeneral.org/doctors/doctor.aspx?id=19711

2020 TTF EGFR QA PANEL Updates on the Combination Treatment of Osimertinib (Tagrisso) and Ramucirumab (Cyramza)
2020 Targeted Therapy Patient Forum EGFR QA PANEL - Updates on the Combination Treatment of Osimertinib (Tagrisso) and Ramucirumab (Cyramza)
Author
Zofia (Zosia) Piotrowska, MD, GRACE Faculty
Image
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum.

This year's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.

This day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the EGFR Breakout Session, Drs. Jared Weiss and Zofia Piotrowska answer questions from attendees of the event.

 

For this video, they discuss updates on the combination therapy treatment of Osimertinib (Tagrisso) and Ramucirumab (Cyramza)

 

We thank our sponsors for their support of this event! AstraZeneca, Lilly, Novartis, Takeda, Foundation Medicine, Boehringer Ingelheim, Blueprint Medicines and Genentech

 

Access to the full agenda can be found here: https://bit.ly/39131em

Full bios for attending faculty can be found here: https://bit.ly/2M0FVLH

To join the conversation, visit https://cancergrace.org/forum.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora
Image
Clinical Trials Storytelling 2025
Article
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.